ALTEOGEN And 2 Other KRX Growth Stocks With Strong Insider Confidence

In the last week, the South Korean market has remained flat, yet it is up 6.4% over the past year with earnings forecasted to grow by 31% annually. In such a promising environment, stocks that exhibit high insider ownership often indicate strong confidence from those closest to the company, making them potential candidates for growth-focused investors seeking alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.4%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.8%	49.1%
Bioneer (KOSDAQ:A064550)	15.8%	97.6%
Oscotec (KOSDAQ:A039200)	26.1%	122%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
HANA Micron (KOSDAQ:A067310)	18.3%	100.3%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%
INTEKPLUS (KOSDAQ:A064290)	16.3%	96.7%

Click here to see the full list of 85 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩19.60 trillion.

Operations: The company's revenue is primarily derived from its biotechnology segment, totaling ₩90.79 billion.

Insider Ownership: 26.6%

ALTEOGEN's revenue is forecast to grow significantly at 64.2% annually, surpassing the South Korean market's 10.5% growth rate. Despite past shareholder dilution, the stock trades at a substantial discount to its estimated fair value. Earnings are projected to rise sharply by 99.46% per year, with profitability expected within three years and a very high return on equity anticipated in that timeframe, indicating strong growth potential despite limited recent insider trading activity.

• Navigate through the intricacies of ALTEOGEN with our comprehensive analyst estimates report here.
• Upon reviewing our latest valuation report, ALTEOGEN's share price might be too optimistic.

Enchem (KOSDAQ:A348370)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩4.24 billion.

Operations: The company generates revenue from its Electronic Components & Parts segment, amounting to ₩348.75 million.

Insider Ownership: 19.4%

Enchem's revenue is forecasted to grow significantly at 63% annually, outpacing the South Korean market's 10.5% growth rate. Earnings are projected to increase sharply by 155.2% per year, with profitability expected within three years, indicating strong growth potential despite past shareholder dilution and high share price volatility. The absence of recent insider trading activity suggests a stable insider ownership structure amidst these growth prospects.

• Unlock comprehensive insights into our analysis of Enchem stock in this growth report.
• According our valuation report, there's an indication that Enchem's share price might be on the expensive side.

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management, with a market cap of ₩7.45 trillion.

Operations: The company's revenue segments include Label at ₩1.28 trillion, Platform at ₩361.12 billion, and Solution at ₩1.24 trillion.

Insider Ownership: 32.5%

HYBE is experiencing significant earnings growth, forecasted at 42.2% annually, surpassing the South Korean market average of 30.6%. Despite recent challenges in net income and earnings per share, the company remains undervalued by 23.9% against fair value estimates. Its share repurchase program aims to stabilize stock prices, reflecting confidence in future performance despite low insider trading activity over the past three months and a projected modest return on equity of 9.8%.

• Click here and access our complete growth analysis report to understand the dynamics of HYBE.
• The valuation report we've compiled suggests that HYBE's current price could be quite moderate.

Make It Happen

• Unlock our comprehensive list of 85 Fast Growing KRX Companies With High Insider Ownership by clicking here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com